• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
261.42 1 (0.45%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    258.66

  • Today’s High

    265.00

  • Open

    261.40

  • Perv Close

    260.24

  • 52W Low

    130.00

  • 52W High

    358.70

Key Indicators

  • P/E(TTM)

    63.02

  • Mar.Cap (₹Cr.)

    11,846.61

  • Div & Yield %

    0.31

  • Book Value(₹)

    30.53

  • Debt-Equity Ratio

    0.45

  • AGM Date

    30-May-2025

  • EPS

    4.15

  • P/E Ratio

    63.02

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    11,846.61

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    30.50

  • Sales( ₹ in Cr.)

    1,174.37

  • NP (in Cr.)

    188.27

  • NP Var(%)

    41.0

  • Div%

    80.0

  • CPS (₹)

    4.80

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    11,852.50

  • 52 Week High

    358.70

  • 52 Week Low

    130.00

  • Price BSE

    262.0

  • Price NSE

    261.00

  • Market Capital( in Cr.)

    11,852.50

  • P/C Ratio

    54.50

  • P/E Ratio

    63.10

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 853.27 655.20 658.29 599.55 433.42 424.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 853.27 655.20 658.29 599.55 433.42 424.16
Other Income 62.07 60.48 42.25 31.16 0.17 7.93
Stock Adjustments 7.25 10.19 -3.89 -0.55 5.63 2.71
Total Income 922.59 725.87 696.65 630.16 439.22 434.80
EXPENDITURE :            
Raw Materials 486.18 404.64 373.70 337.36 251.04 239.05
Power and Fuel Cost 26.04 14.24 11.49 10.90 8.68 8.22
Employee Cost 77.19 56.09 60.46 54.64 48.51 46.33
Other Manufacturing Expenses 41.61 21.09 5.25 6.98 4.76 8.38
Selling and Administration Expenses 81.00 61.54 67.57 60.08 43.86 47.18
Miscellaneous Expenses 8.56 15.89 22.22 15.31 10.70 14.38
Employee Benefit Expenses 77.19 56.09 60.46 54.64 48.51 46.33
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 720.58 573.49 540.68 485.28 367.55 363.54
Operating Profit 202.01 152.38 155.97 144.87 71.66 71.26
Interest 0.99 3.61 3.80 5.35 7.29 6.56
Gross Profit 201.02 148.77 152.17 139.52 64.37 64.70
Depreciation 29.13 16.74 17.66 15.19 11.64 8.69
Profit Before Tax 171.89 132.03 134.51 124.33 52.73 56.01
Current Tax 37.46 29.34 30.02 28.19 11.15 11.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.68 -0.17 0.50 -2.24 3.68 1.00
Reported Net Profit 133.76 102.87 103.99 98.38 37.90 43.62
Extraordinary Items 0.07 -0.05 0.00 0.03 0.03 -0.03
Adjusted Net Profit 133.69 102.92 103.99 98.35 37.87 43.65
Adjustment below Net Profit 0.28 -8.64 0.05 -0.20 -0.39 0.03
P & L Balance brought forward 233.61 155.21 61.41 -32.69 -62.74 -104.34
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 22.66 15.82 10.23 4.09 7.47 2.05
P & L Balance carried down 345.00 233.61 155.21 61.41 -32.69 -62.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 50.00 25.00 25.00 10.00 5.00
Dividend Per Share(Rs) 0.60 0.50 0.25 0.25 0.10 0.05
Earnings Per Share-Unit Curr 2.95 2.27 2.54 2.40 0.93 1.07
Earnings Per Share(Adj)-Unit Curr 2.95 2.27 2.54 2.40 0.93 1.07
Book Value 26.98 24.52 16.90 14.65 12.35 11.50
Book Value(Adj)-Unit Curr 26.98 24.52 16.90 14.65 12.35 11.50

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 49,324,324 10.88 49,324,324 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 51,286,765 11.32 51,286,765 134
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 15,293,537 3.37 15,293,537 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,359,741 1.18 5,359,741 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 121,267,278 26.76 121,265,278 153
2] Non Institution
Bodies Corporate 5,881,787 1.30 5,880,787 718
Clearing Members 94,482 0.02 94,482 40
Directors of their Relatives 0 0.00 0 0
Employees 4,265 0.00 4,265 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,136,823 1.35 6,136,823 4,207
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,318,906 0.73 3,318,906 2,589
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,217,353 3.80 17,217,353 30
Individuals holding nominal share capital up to Rs. 1 lakh 99,584,499 21.98 99,319,679 249,522
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,455 0.00 3,455 3
Others 827,790 0.18 827,790 1
Sub Total 133,074,459 29.37 132,808,639 257,118
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,895,926 257,273

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    Harshavardhan Panigrahi

  • Auditor

    MSKA & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 261.55 915.35 853.27 63.02 14.67
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92